To predict the potential interaction effects of HP on these five key targets in MDD, we used three major active ingredients of HP, including quercetin, kaempferol, and luteolin, to dock with MAPK1, EGF, HSP90AA1, AKT1, and MYC, respectively (Fig. 10A, B). The gene discussed is MYC; the disease is major depressive disorder.